We hope you have already discovered the DiabetesMine Test Kitchen — our new crowdsourced hub for video reviews of diabetes products, launched on Monday.
Essentially, we at the ‘Mine believe that people with diabetes are at a disadvantage as consumers – after all, where can we patients post and explore user reviews of products aimed at our chronic disease care, like other consumers can do for any variety of products?
We aim to…
Our friend David Edelman is a rock star in the Diabetes Online Community, having co-created Diabetes Daily, one of the top community sites that has grown to include a huge number of forums, blog posts, recipes and useful tidbits for people with diabetes.
(David does not have diabetes himself, but he experienced diagnosis with his wife in 2005, and has been devoted to the cause ever since.)
We were excited to hear the news in…Read more »
It almost seems that a new era of alternative test strips and other “basic” diabetes products has hit. It’s a sign of the times, really, as big-name brands are hurting because of Medicare competitive bidding changes that are limiting access to pricier products in favor of more economical options — giving producers of generics a fresh entry point into the market.
Last week, a company called UniStrip Technologies announced availability of a new FDA-approved generic…
Ah, non-invasive glucose testing. It’s the dreamed-about Holy Grail of Diabetes, something we know could someday exist but seems to remain just beyond reach.
There have been oodles of attempts at non-invasive approaches through the years — everything from the failed GlucoWatch concept to more recent designs promising glucose readings through tattoos, tears, sweat, saliva, fingerprint and eyeball scans, and even contact lenses.
Now there’s another one on the scene, Folks. This one is called…
Nothing is perfect. That can certainly be said for the comprehensive front-page article the New York Times ran this Saturday, April 5, on the high cost of new type 1 diabetes tools. While the story was one of the best we’ve seen in describing the challenges of insulin dependence and the huge cost barriers that exist for patients in our convoluted American healthcare system, some felt that it actually disses innovation in diabetes tools –…Read more »